Heads-Up: Stephen Lerner at Squire Patton Boggs in Cincinnati

Stephen Lerner, global chair of Squire Patton Boggs’ restructuring group, tells GRR it will be a “big day” when the Second Circuit hands down its decision in Purdue Pharma on whether third party releases are permitted or not – an issue, he says, many lawyers thought was “dead and buried at this point”.

Unlock unlimited access to all Global Restructuring Review content